{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:00Z","timestamp":1761518880511},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1507\/endocrj.k07-078","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T05:51:04Z","timestamp":1205819464000},"page":"41-48","source":"Crossref","is-referenced-by-count":4,"title":["Association between Baseline Values of Bone Turnover Markers and Bone Mineral Density and Their Response to Raloxifene Treatment in Japanese Postmenopausal Women with Osteoporosis"],"prefix":"10.1507","volume":"55","author":[{"given":"Takafumi","family":"MAJIMA","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Clinical Research Institute for Endocrine Metabolic Diseases, National Hospital Organization"},{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine"},{"name":"Department of General Medicine, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"SHIMATSU","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Clinical Research Institute for Endocrine Metabolic Diseases, National Hospital Organization"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasato","family":"KOMATSU","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"SATOH","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Clinical Research Institute for Endocrine Metabolic Diseases, National Hospital Organization"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"FUKAO","sequence":"additional","affiliation":[{"name":"First Department of Nursing, Ainogakuin College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"NINOMIYA","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"MATSUMURA","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"NAKAO","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1424-1"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-006-0702-3"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.637"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040211"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170020"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301243"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.1.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Delmas PD, Zhengqing LI, Cooper C (2004) Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses. J Bone Miner Res 19: 330-337.","DOI":"10.1359\/JBMR.0301228"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Iwamoto J, Takeda T, Sato Y, Uzawa M (2004) Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis. Yonsei Med J 45: 676-682","DOI":"10.3349\/ymj.2004.45.4.676"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.6.1693"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.9.1431"},{"key":"12","unstructured":"12. Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C (1999) Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J Clin Endocrinol Metab 84: 2363-2368."},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.52.667"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.6.1051"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, Thompson DE, Ewing SK, Delmas PD (2004) Change in bone turnover and hip, nonspine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 19: 1250-1258.","DOI":"10.1359\/JBMR.040512"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Civitelli R, Gonelli S, Sachei F (1988) Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 82: 1268-1274.","DOI":"10.1172\/JCI113725"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chesnut C, Bell N, Clark G, Drinkwater B, English S, Johnson CJ, Notelovitz M, Rosen C, Cain D, Flessland K, Mallinak N (1997) Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 20: 29-37.","DOI":"10.1016\/S0002-9343(96)00387-7"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.6.1904"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K (2007) Clinical Significance of 1-year treatment with Raloxifene on Bone and Lipid Metabolism in Japanese Postmenopausal Women with Osteoporosis. Endocr J (in press).","DOI":"10.1507\/endocrj.K06-208"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K (2007) 3-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis. J Bone Miner Metab (in press).","DOI":"10.1007\/s00774-007-0807-3"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1007\/s007740170001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD (2003) Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33: 522-532.","DOI":"10.1016\/S8756-3282(03)00241-2"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050509"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.985"},{"key":"25","unstructured":"25. Johnell O, Kanis JA, Sarkar S, Wu W, De Laet C, Oden A, Pavo I (2001) Relationship between age and prior use of HRT and vertebral fracture risk reduction with raloxifene in postmenopausal women: Results from the MORE trial. J Bone Miner Res 16: S1; S414."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/55\/1\/55_K07-078\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:45:40Z","timestamp":1618296340000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/55\/1\/55_K07-078\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k07-078","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}